These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17256924)

  • 1. Molecular-docking-guided design, synthesis, and biologic evaluation of radioiodinated quinazolinone prodrugs.
    Chen K; Aowad AF; Adelstein SJ; Kassis AI
    J Med Chem; 2007 Feb; 50(4):663-73. PubMed ID: 17256924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico design, synthesis, and biological evaluation of radioiodinated quinazolinone derivatives for alkaline phosphatase-mediated cancer diagnosis and therapy.
    Chen K; Wang K; Kirichian AM; Al Aowad AF; Iyer LK; Adelstein SJ; Kassis AI
    Mol Cancer Ther; 2006 Dec; 5(12):3001-13. PubMed ID: 17172404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of chemical, physical, and biologic properties of tumor-targeting radioiodinated quinazolinone derivative.
    Wang K; Kirichian AM; Aowad AF; Adelstein SJ; Kassis AI
    Bioconjug Chem; 2007; 18(3):754-64. PubMed ID: 17385903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational modeling and experimental evaluation of a novel prodrug for targeting the extracellular space of prostate tumors.
    Pospisil P; Wang K; Al Aowad AF; Iyer LK; Adelstein SJ; Kassis AI
    Cancer Res; 2007 Mar; 67(5):2197-205. PubMed ID: 17332350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biologic evaluation of a radioiodinated quinazolinone derivative for enzyme-mediated insolubilization therapy.
    Ho NH; Harapanhalli RS; Dahman BA; Chen K; Wang K; Adelstein SJ; Kassis AI
    Bioconjug Chem; 2002; 13(2):357-64. PubMed ID: 11906274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational and biological evaluation of quinazolinone prodrug for targeting pancreatic cancer.
    Pospisil P; Korideck H; Wang K; Yang Y; Iyer LK; Kassis AI
    Chem Biol Drug Des; 2012 Jun; 79(6):926-34. PubMed ID: 22304734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular simulation of ligand-binding with DNA: implications for 125I-labeled pharmaceutical design.
    Chen K; Adelstein SJ; Kassis AI
    Int J Radiat Biol; 2004; 80(11-12):921-6. PubMed ID: 15764403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural studies of human placental alkaline phosphatase in complex with functional ligands.
    Llinas P; Stura EA; Ménez A; Kiss Z; Stigbrand T; Millán JL; Le Du MH
    J Mol Biol; 2005 Jul; 350(3):441-51. PubMed ID: 15946677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and in vitro evaluation of novel water-soluble prodrugs of buparvaquone.
    Mäntylä A; Rautio J; Nevalainen T; Keski-Rahkonen P; Vepsälainen J; Järvinen T
    Eur J Pharm Sci; 2004 Oct; 23(2):151-8. PubMed ID: 15451003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and anti-cancer efficacy of rapid hydrolysed water-soluble paclitaxel pro-drugs.
    Ryu BY; Sohn JS; Hess M; Choi SK; Choi JK; Jo BW
    J Biomater Sci Polym Ed; 2008; 19(3):311-24. PubMed ID: 18325233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and cytotoxicity testing of novel 2-(3-substituted-6-chloro-1,1-dioxo-1,4,2-benzodithiazin-7-yl)-3-phenyl-4(3H)-quinazolinones.
    Pomarnacka E; Maruszak M; Langowska K; Reszka P; Bednarski PJ
    Arch Pharm (Weinheim); 2008 Aug; 341(8):485-90. PubMed ID: 18618486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human placental alkaline phosphatase-mediated hydrolysis correlates tightly with the electrostatic contribution from tail group.
    Yang Y; Wang K; Li W; Adelstein SJ; Kassis AI
    Chem Biol Drug Des; 2011 Dec; 78(6):923-31. PubMed ID: 21910833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of structurally constrained quinazolinone derivatives as potent and selective histamine H3 receptor inverse agonists.
    Nagase T; Mizutani T; Sekino E; Ishikawa S; Ito S; Mitobe Y; Miyamoto Y; Yoshimoto R; Tanaka T; Ishihara A; Takenaga N; Tokita S; Sato N
    J Med Chem; 2008 Nov; 51(21):6889-901. PubMed ID: 18841880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel quinazolinone derivatives as 5-HT7 receptor ligands.
    Na YH; Hong SH; Lee JH; Park WK; Baek DJ; Koh HY; Cho YS; Choo H; Pae AN
    Bioorg Med Chem; 2008 Mar; 16(5):2570-8. PubMed ID: 18083580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel prodrug approach for tertiary amines: synthesis and preliminary evaluation of N-phosphonooxymethyl prodrugs.
    Krise JP; Zygmunt J; Georg GI; Stella VJ
    J Med Chem; 1999 Aug; 42(16):3094-100. PubMed ID: 10447953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, structure-activity relationships, and biological profiles of a quinazolinone class of histamine H3 receptor inverse agonists.
    Nagase T; Mizutani T; Ishikawa S; Sekino E; Sasaki T; Fujimura T; Ito S; Mitobe Y; Miyamoto Y; Yoshimoto R; Tanaka T; Ishihara A; Takenaga N; Tokita S; Fukami T; Sato N
    J Med Chem; 2008 Aug; 51(15):4780-9. PubMed ID: 18598020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioreversible quaternary N-acyloxymethyl derivatives of the tertiary amines bupivacaine and lidocaine--synthesis, aqueous solubility and stability in buffer, human plasma and simulated intestinal fluid.
    Nielsen AB; Buur A; Larsen C
    Eur J Pharm Sci; 2005 Apr; 24(5):433-40. PubMed ID: 15784333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrophosphate-bridged complexes with picomolar toxicity.
    Ikotun OF; Higbee EM; Ouellette W; Doyle RP
    J Inorg Biochem; 2009 Sep; 103(9):1254-64. PubMed ID: 19666193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, in vitro and in vivo characterization of novel ethyl dioxy phosphate prodrug of propofol.
    Kumpulainen H; Järvinen T; Mannila A; Leppänen J; Nevalainen T; Mäntylä A; Vepsäläinen J; Rautio J
    Eur J Pharm Sci; 2008 Jul; 34(2-3):110-7. PubMed ID: 18403185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design of conformationally restricted quinazolinone inhibitors of poly(ADP-ribose)polymerase.
    Hattori K; Kido Y; Yamamoto H; Ishida J; Iwashita A; Mihara K
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5577-81. PubMed ID: 17804225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.